arrow_back Back to App

Easier Approval for Generic Animal Drugs

New rules aim to simplify the market entry of generic animal drugs, potentially lowering prices and increasing availability. The changes focus on how these drugs are approved, especially regarding bioequivalence studies.
Key points
Streamlining the approval process for generic animal drugs, which could lead to more competition and lower costs.
Requiring proof of bioequivalence for generic drugs in at least one major animal species for which the original drug is approved.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1683
Sponsor: Rep. Mace, Nancy [R-SC-1]
Process start date: 2023-03-21